About us
About UNIQUE therapeutics
The story of UNIQUE THERAPEUTICS INC. begins in Canada in 1999. Radek Hlaváček and his partners test new, more effective ways of delivering active ingredients to the body in a former laboratory. The first recipe for CBD NANO up to 20nm is created.
UNIQUE THERAPEUTICS INC. then decided to expand production to its native Czech Republic in 2019 and a laboratory was establisThanks to the right timing and a good team, the operation quickly increased and UNIQUE produces products for more than 13 retail brands. As a result, the operation also expanded to include cannabigerol (CBG) and tetrahydrocannabinol (THC) in nano form. UNIQUE THERAPEUTICS INC. thus becomes the first company to offer these substances in a liposomal form with a size of 20 nm worldwide.
In 2021, a contract is signed and research begins with ICRC (a research institute at the University Hospital of St. Anne in Brno). In 2022, together with our leading institutions, we expand the use of nanoliposomes in the pharmaceutical industry. UNIQUE is here for you as an alternative solution using the most modern production technologies combined with natural substances that have been healing us for millennia.
The goal of UNIQUE THERAPEUTICS INC. is to launch new, innovative products in nanoliposomal form with high bioavailability, rapid efficacy and minimal doses.
